Log in

Antares Pharma SEC Filings & 10K Form (NASDAQ:ATRS)

$4.11
-0.13 (-3.07 %)
(As of 01/24/2020 06:00 AM ET)
Today's Range
$4.10
Now: $4.11
$4.24
50-Day Range
$4.11
MA: $4.56
$4.89
52-Week Range
$2.60
Now: $4.11
$5.13
Volume1.24 million shs
Average Volume1.22 million shs
Market Capitalization$670.88 million
P/E Ratio411.41
Dividend YieldN/A
Beta0.92

SEC Filings

Antares Pharma (NASDAQ:ATRS) SEC Filings

DateFilerForm TypeView
01/14/2020
5:07 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/13/2020
8:06 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
5:06 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:57 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
6:24 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
6:21 PM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2019
6:15 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:35 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2019
4:32 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2019
6:30 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2019
6:01 AM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2019
5:59 AM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2019
4:00 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
6:05 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/23/2019
4:03 PM
Antares Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/05/2019
3:00 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2019
7:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2019
3:00 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2019
9:01 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
4:51 PM
Antares Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:49 PM
Antares Pharma (Issuer)
Greenleaf Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:46 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:43 PM
Antares Pharma (Issuer)
ROCHE ROBERT P JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:41 PM
Antares Pharma (Issuer)
GUETH ANTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:39 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:36 PM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:34 PM
Antares Pharma (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:32 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:30 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2019
4:28 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
4:43 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
4:40 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2019
4:38 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
4:14 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2019
4:13 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
4:30 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
6:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:26 PM
Antares Pharma (Filer)
Form DEF 14A
04/10/2019
4:49 PM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2019
4:13 PM
Antares Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2019
5:02 PM
Antares Pharma (Issuer)
Smith Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2019
4:55 PM
Antares Pharma (Issuer)
Smith Karen L. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/05/2019
9:01 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
9:33 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2019
4:30 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2019
6:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/22/2019
5:47 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:45 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
4:30 PM
Antares Pharma (Subject)
UBS Group AG (Filed by)
Form SC 13G
02/14/2019
1:27 PM
Antares Pharma (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
Form SC 13G/A
02/04/2019
9:07 AM
Antares Pharma (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/07/2019
6:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2018
5:49 PM
Antares Pharma (Issuer)
Greenleaf Peter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
5:46 PM
Antares Pharma (Issuer)
Greenleaf Peter (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/13/2018
9:24 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2018
6:01 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2018
3:42 PM
Antares Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2018
5:59 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/04/2018
5:00 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
8:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/06/2018
2:45 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2018
4:11 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
5:03 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
4:19 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
5:14 PM
Antares Pharma (Issuer)
Tursi James Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
5:07 PM
Antares Pharma (Issuer)
Tursi James Patrick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2018
6:15 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2018
4:51 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:12 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2018
4:24 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
6:20 PM
Antares Pharma (Issuer)
SAMSON MARVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
6:19 PM
Antares Pharma (Issuer)
ROCHE ROBERT P JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
6:18 PM
Antares Pharma (Issuer)
JACOB LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
6:15 PM
Antares Pharma (Issuer)
GUETH ANTON (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
6:14 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
6:12 PM
Antares Pharma (Issuer)
GARRITY THOMAS J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
6:09 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
6:07 PM
Antares Pharma (Issuer)
Powell Fred M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
6:06 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2018
6:16 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
4:54 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
4:53 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
4:51 PM
Antares Pharma (Issuer)
GRAHAM PETER J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2018
8:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
4:52 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2018
4:54 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2018
4:47 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2018
4:54 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2018
4:42 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2018
4:55 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
5:23 PM
Antares Pharma (Issuer)
APPLE ROBERT F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2018
5:21 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2018
4:34 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2018
6:00 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
3:01 PM
Antares Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2018
6:35 AM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2018
4:35 PM
Antares Pharma (Issuer)
GONELLA JACQUES (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
3:05 PM
Antares Pharma (Filer)
Form DEF 14A
03/27/2018
3:53 PM
Antares Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2018
3:01 PM
Antares Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
This page was last updated on 1/24/2020 by MarketBeat.com Staff

Featured Article: What is the quiet period?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel